Achilles Therapeutics plc (ACHL)
NASDAQ: ACHL · IEX Real-Time Price · USD
0.948
+0.010 (1.03%)
At close: May 17, 2024, 4:00 PM
0.960
+0.012 (1.29%)
After-hours: May 17, 2024, 7:49 PM EDT
Achilles Therapeutics Market Cap
Achilles Therapeutics has a market cap or net worth of $38.40 million as of May 17, 2024. Its market cap has decreased by -1.28% in one year.
Market Cap
38.40M
Enterprise Value
-69.71M
1-Year Change
-1.28%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on March 31, 2021, Achilles Therapeutics's market cap has decreased from $731.19M to $38.40M, a decrease of -94.75%. That is a compound annual growth rate of -61.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2024 | 37.60M | -0.53% |
May 15, 2024 | 37.80M | - |
May 14, 2024 | 37.80M | 3.28% |
May 13, 2024 | 36.60M | -5.18% |
May 10, 2024 | 38.60M | 2.12% |
May 9, 2024 | 37.80M | - |
May 8, 2024 | 37.80M | 11.50% |
May 7, 2024 | 33.90M | -0.59% |
May 6, 2024 | 34.10M | 3.33% |
May 3, 2024 | 33.00M | 3.13% |
May 2, 2024 | 32.00M | -0.31% |
May 1, 2024 | 32.10M | 4.22% |
Apr 30, 2024 | 30.80M | -1.28% |
Apr 29, 2024 | 31.20M | - |
Apr 26, 2024 | 31.20M | -1.89% |
Apr 25, 2024 | 31.80M | -1.24% |
Apr 24, 2024 | 32.20M | 0.31% |
Apr 23, 2024 | 32.10M | -1.23% |
Apr 22, 2024 | 32.50M | 0.93% |
Apr 19, 2024 | 32.20M | -2.13% |
Apr 18, 2024 | 32.90M | -1.79% |
Apr 17, 2024 | 33.50M | 1.82% |
Apr 16, 2024 | 32.90M | -2.66% |
Apr 15, 2024 | 33.80M | -3.15% |
Apr 12, 2024 | 34.90M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Renalytix | 39.55M |
OncoCyte | 39.49M |
Unicycive Therapeutics | 39.49M |
Quince Therapeutics | 38.89M |
Precision Optics Corporation | 38.84M |
Sensei Biotherapeutics | 38.37M |
American Oncology Network | 38.29M |
Estrella Immunopharma | 38.07M |